{"id":110803,"date":"2021-01-19T16:56:42","date_gmt":"2021-01-19T23:56:42","guid":{"rendered":"http:\/\/www.lankaweb.com\/news\/items\/?p=110803"},"modified":"2021-01-19T16:56:42","modified_gmt":"2021-01-19T23:56:42","slug":"russias-second-vaccine-100-effective-watchdog-tells-media","status":"publish","type":"post","link":"https:\/\/www.lankaweb.com\/news\/items\/2021\/01\/19\/russias-second-vaccine-100-effective-watchdog-tells-media\/","title":{"rendered":"Russia\u2019s second vaccine \u2019100% effective\u2019, watchdog tells media"},"content":{"rendered":"

Courtesy The Daily Mirror<\/em><\/span><\/h2>\n\n\n

A candidate COVID-19 vaccine known as EpiVacCorona, Russia\u2019s second to be registered, proved 100% effective\u201d in early-stage trials, Russian consumer health watchdog Rospotrebnadzor has told local media.<\/p>\n\n\n\n

The data, based on Phase I and II trials, were released before the start of a larger Phase III trial which would normally involve thousands of participants and a placebo group as a comparison, Reuters reported.<\/p>\n\n\n\n

The effectiveness of the vaccine is made up of its immunological effectiveness and preventative effectiveness,\u201d the TASS news agency reported, citing Rospotrebnadzor.<\/p>\n\n\n\n

According to results of the first and second phases of clinical trials, the immunological effectiveness of the EpiVacCorona vaccine is 100%.\u201d<\/p>\n\n\n\n

The Phase I and II studies tested the safety, side-effects and immunogenicity of the potential vaccine in 100 people aged 18-60, according to the state trials register.<\/p>\n\n\n\n

Typically early-stage vaccine tests on humans are based on blood readings showing an immune response in participants who have not been exposed to the virus, while the results of larger late-stage trials are based on actual infections suffered by participants in their normal lives.<\/p>\n\n\n\n

Russia began testing EpiVacCorona, which is being developed by Siberia\u2019s Vector Institute, in November.<\/p>\n\n\n\n

Earlier that month, Moscow said its other approved vaccine, Sputnik V, was 92% effective at protecting people from COVID-19 based on interim results.<\/p>\n\n\n\n

Russia has said it can inoculate 60% of its population against COVID-19 this year, and although the Sputnik V vaccine has been readily available in Moscow, the rollout across the country has been slow.<\/p>\n\n\n\n

Russian President Vladimir Putin has ordered mass vaccinations to start this week.<\/p>\n\n\n\n

EpiVacCorona will be used in mass vaccinations from March, Deputy Prime Minister Tatiana Golikova told the Interfax news agency.<\/p>\n\n\n\n

Russia has reported 3,612,800 coronavirus cases, the world\u2019s fourth-highest total. Its death toll from the virus stands at 66,623.<\/p>\n","protected":false},"excerpt":{"rendered":"

Courtesy The Daily Mirror A candidate COVID-19 vaccine known as EpiVacCorona, Russia\u2019s second to be registered, proved 100% effective\u201d in early-stage trials, Russian consumer health watchdog Rospotrebnadzor has told local media. The data, based on Phase I and II trials, were released before the start of a larger Phase III trial which would normally involve […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":true,"template":"","format":"standard","meta":{"footnotes":""},"categories":[174],"tags":[],"class_list":["post-110803","post","type-post","status-publish","format-standard","hentry","category--19-"],"_links":{"self":[{"href":"https:\/\/www.lankaweb.com\/news\/items\/wp-json\/wp\/v2\/posts\/110803","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lankaweb.com\/news\/items\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.lankaweb.com\/news\/items\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.lankaweb.com\/news\/items\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lankaweb.com\/news\/items\/wp-json\/wp\/v2\/comments?post=110803"}],"version-history":[{"count":0,"href":"https:\/\/www.lankaweb.com\/news\/items\/wp-json\/wp\/v2\/posts\/110803\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.lankaweb.com\/news\/items\/wp-json\/wp\/v2\/media?parent=110803"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.lankaweb.com\/news\/items\/wp-json\/wp\/v2\/categories?post=110803"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.lankaweb.com\/news\/items\/wp-json\/wp\/v2\/tags?post=110803"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}